About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,584 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,584 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 861-880 of 6,584 trials

CompletedStudy of the Emotional Needs of Caregivers of Stem Cell Transplantation PatientsRATIONALE: Understanding the emotional needs of spouses or others who are living with and caring for patients who have undergone stem cell transplantation may help improve the…NCT00082654·Seattle, Washington CompletedPhase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental FatTo evaluate the safety and potential efficacy of deoxycholic acid injection compared to placebo for the reduction of submental fat (fat below the chin).NCT00618722·Carina Heights and 5 others CompletedPrimary Bone Mature B-Cell NHL in ChildrenBackground:Primary bone mature B-cell lymphomas (PB-BCL) are rare in children and adolescents. Current data on their clinical presentation, management, and outcomes remain limited.NCT07721194·Nice, Alpes Maritimes

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

CompletedThe Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL)1.NCT00930605·Bangkok

UnknownLow Grade LymphomaThe purpose of this study is to assess the seroconversion rate and the cellular immune response after vaccination against hepatitis B virus in patients with lymphoproliferative…NCT01698866·Vandœuvre-lès-Nancy

CompletedTrial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and LymphomaThis is a phase 2 study looking at efficacy and toxicity of oral sirolimus in combination with oral methotrexate in children with refractory/relapsed ALL or NHL.NCT01162551·Philadelphia, Pennsylvania

CompletedEffects of Structured Physical Activity Breaks and Free Play in Children With Mild Intellectual DisabilityChildren with mild intellectual disability (MID) typically exhibit delays in both intellectual and adaptive functioning, with the onset occurring during the developmental period.NCT06943196·Lahore, Punjab Province

CompletedStem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell LymphomaRATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00052923

CompletedIdentifying Immune-related Biomarkers to Predict the Efficacy of Cancer ImmunotherapyThe development of Immune Checkpoint Blockade (ICB) is a revolution in medical oncology as ICB have changed the standard treatments of several metastatic tumor types.NCT03595813·Marseille, Bouches-du-Rhône

CompletedStem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary SyndromeThis study will investigate the safety and effectiveness of a modified donor stem cell transplantation procedure for treating advanced mycosis fungoides (MF), a lymphoma primarily…NCT00047060·Bethesda, Maryland

UnknownImproving the Outcome of High-risk Aggressive B-cell Lymphoma Patients With Nivolumab Maintenance TherapyThis trial is designed as a unicenter, single arm phase II trial.NCT03569696·Ramat Gan

CompletedA Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.This study was a randomized, single dose crossover comparison of the investigational product with a Reference Product (vinorelbine tartrate injection, NAVELBINE®).NCT00432562·Buenos Aires and 4 others

WithdrawnObatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaThis phase I/II trial is studying the side effects and the best dose of obatoclax mesylate when given together with rituximab and bendamustine hydrochloride to see how well it…NCT01238146·Columbus, Ohio

RecruitingIKS03 in Patients With Advanced B Cell Non-Hodgkin LymphomasThis first-in-human study will evaluate the recommended dose for further clinical development, safety, tolerability, antineoplastic activity, immunogenicity, pharmacokinetics and…NCT05365659·Baltimore, Maryland and 12 others

Active not recruitingLIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin LymphomaPrevention and treatment of CNS relapse remains a great unmet clinical need in the management of aggressive B-NHL.NCT06090162·Aarau and 13 others

TerminatedA Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell LymphomaTo evaluate the safety and efficacy of lenalidomide (Revlimid ®) in combination with dexamethasone in subjects with relapsed or refractory diffuse large B-cell lymphoma.NCT00474188·Glendale, Arizona and 23 others

TerminatedDonor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic CancerRationale: Giving chemotherapy and total-body irradiation before a donor umbilical cord blood transplant helps stop the growth of cancer and abnormal cells and helps stop the…NCT00295880

CompletedBCX-1777 in Treating Patients With Refractory Cutaneous T-Cell LymphomaRATIONALE: BCX-1777 may stop the growth of cancer cells by blocking the enzymes necessary for cancer cell growth.NCT00061880·Birmingham, Alabama and 2 others

Not yet recruitingTreatment of CIK for Patients With Refractory Non-Hodgkin LymphomaThe purpose of this study is to study the safety and efficacy of chemotherapy usage followed by CIK transfusion in refractory and/or chemoresistant lymphomas.NCT02497898

UnknownThe Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin LymphomaThis is a single arm, open-label study to evaluate the safety, tolerance and efficacy of CD20 CAR-T Cells in patients with relapsed and refractory B cell non-Hodgkin Lymphoma.NCT04169932·Nanjing, Jiangsu

PreviousPage 44 of 330Next